Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anjali Yadava

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Plos Neglected Tropical Diseases|January 13, 2017
Rationale for Further Development of a Vaccine Based on the Circumsporozoite Protein of Plasmodium vivaxAnjali Yadava, Norman C Waters
Infection and Immunity|August 23, 2003
Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systemsAnjali Yadava, Christian F Ockenhouse
The Journal of Infectious Diseases|October 5, 2021
Response to Odedra et alEdwin Kamau, Jason W Bennett, Anjali Yadava
The Journal of Infectious Diseases|June 23, 2021
Safety and Tolerability of Mosquito Bite-Induced Controlled Human Infection with Plasmodium vivax in Malaria-Naive Study Participants-Clinical Profile and Utility of Molecular Diagnostic MethodsEdwin Kamau, Jason W Bennett, Anjali Yadava
The Journal of Infectious Diseases|March 30, 2012
Cross-species immunity following immunization with a circumsporozoite protein-based vaccine for malariaAnjali Yadava, Saule Nurmukhambetova, Alexander V Pichugin, et al.
Vaccine|October 14, 2015
Particle-based platforms for malaria vaccinesYimin Wu, David L Narum, Sylvain Fleury, et al.
Infection and Immunity|August 23, 2005
Genome-wide expression profiling in malaria infection reveals transcriptional changes associated with lethal and nonlethal outcomesKurt Schaecher, Sanjai Kumar, Anjali Yadava, et al.
Frontiers in Immunology|January 23, 2023
The challenges of <i>Plasmodium vivax</i> human malaria infection models for vaccine developmentWanlapa Roobsoong, Anjali Yadava, Simon J Draper, et al.
Infection and Immunity|May 30, 2013
Development of a chimeric Plasmodium berghei strain expressing the repeat region of the P. vivax circumsporozoite protein for in vivo evaluation of vaccine efficacyDiego A Espinosa, Anjali Yadava, Evelina Angov, et al.
Plos One|February 14, 2012
Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccineJames J Moon, Heikyung Suh, Mark E Polhemus, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Plos Neglected Tropical Diseases|January 13, 2017
Rationale for Further Development of a Vaccine Based on the Circumsporozoite Protein of Plasmodium vivaxAnjali Yadava, Norman C Waters
Infection and Immunity|August 23, 2003
Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systemsAnjali Yadava, Christian F Ockenhouse
The Journal of Infectious Diseases|October 5, 2021
Response to Odedra et alEdwin Kamau, Jason W Bennett, Anjali Yadava
The Journal of Infectious Diseases|June 23, 2021
Safety and Tolerability of Mosquito Bite-Induced Controlled Human Infection with Plasmodium vivax in Malaria-Naive Study Participants-Clinical Profile and Utility of Molecular Diagnostic MethodsEdwin Kamau, Jason W Bennett, Anjali Yadava
The Journal of Infectious Diseases|March 30, 2012
Cross-species immunity following immunization with a circumsporozoite protein-based vaccine for malariaAnjali Yadava, Saule Nurmukhambetova, Alexander V Pichugin, et al.
Vaccine|October 14, 2015
Particle-based platforms for malaria vaccinesYimin Wu, David L Narum, Sylvain Fleury, et al.
Infection and Immunity|August 23, 2005
Genome-wide expression profiling in malaria infection reveals transcriptional changes associated with lethal and nonlethal outcomesKurt Schaecher, Sanjai Kumar, Anjali Yadava, et al.
Frontiers in Immunology|January 23, 2023
The challenges of <i>Plasmodium vivax</i> human malaria infection models for vaccine developmentWanlapa Roobsoong, Anjali Yadava, Simon J Draper, et al.
Infection and Immunity|May 30, 2013
Development of a chimeric Plasmodium berghei strain expressing the repeat region of the P. vivax circumsporozoite protein for in vivo evaluation of vaccine efficacyDiego A Espinosa, Anjali Yadava, Evelina Angov, et al.
Plos One|February 14, 2012
Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccineJames J Moon, Heikyung Suh, Mark E Polhemus, et al.
Pageof 3